Search

Your search keyword '"Vaishnaw A"' showing total 447 results

Search Constraints

Start Over You searched for: Author "Vaishnaw A" Remove constraint Author: "Vaishnaw A"
447 results on '"Vaishnaw A"'

Search Results

3. Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases

7. Investigating the Risk of Airborne COVID-19 and the Importance of Social Restrictions in Regulating the Transmission

8. CovidExplorer: A Multi-faceted AI-based Search and Visualization Engine for COVID-19 Information

13. Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity

16. Mathematical model on Post-COVID pulmonary fibrosis: A case study on a COVID patient.

18. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry

19. Exploring the Average Information Parameters over Lung Cancer for Analysis and Diagnosis

21. Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry

27. GC-MS Analysis of Ichnocarpus frutescens (L.) W.T. Aiton Root Hydro-Alcoholic Extract

28. Oil extraction, biochemical activities and in silico analysis for active compound valorization in Azardiricta indica seeds and production of microbial oil using Saccharomyces cerevisiae

31. Nutritional Status of School Age Children in Urban Slum Area in Vijayawada and Guntur

33. Supplementary Tables from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

34. Supplementary Figures from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

35. Data from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

36. Supplementary Methods and Legends from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

37. Supplementary Figures from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

38. Supplementary Methods and Legends from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

39. Supplementary Tables from First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

42. Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy

44. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study

46. Continuous Evolution for 5G: Comprehensive Study and Challenges

Catalog

Books, media, physical & digital resources